Clinical Trials Logo

Clinical Trial Summary

With funding from the Candian Cancer Society, the Men's Healthy Eating Active Living (MHEAL) project began the development, evaluation, and optimization of a program called POWERPLAY to promote men's health at work.


Clinical Trial Description

The MHEAL project began November 2013 and a program (called "POWERPLAY") was developed to support men's active living and healthy eating based on a systematic review of the literature and consultations with groups of men. From 2014-2017 six male-dominated worksites in northern BC offered POWERPLAY and participated in this study. Using a quasi-experimental pre-post design as well as interviews with worksite leads, the program was demonstrated to be an effective, feasible, and acceptable approach to the promotion of modifiable behaviours known to reduce the risk of cancer among working men in northern settings, and several manuscripts were published. Furthermore, the POWERPLAY program was optimized based on feedback received to include friendly competitions, weekly motivational messages, men-friendly language/images, and pedometers, and a manual for employers and website were developed (http://www.powerplayatwork.com/). A new module to support mental well-being was created in 2017 based on a systematic review of the literature for men's mental wellness programs, consultations with men working in northern workplaces, and interviews with workplace representatives. A module to support smoking cessation module was created in 2018. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03548077
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date September 24, 2014
Completion date September 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases